These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19617578)

  • 21. Biochemical characterisation of amyloid by endomyocardial biopsy.
    Benson MD; Breall J; Cummings OW; Liepnieks JJ
    Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.
    Huang G; Ueda M; Tasaki M; Yamashita T; Misumi Y; Masuda T; Suenaga G; Inoue Y; Kinoshita Y; Matsumoto S; Mizukami M; Tsuda Y; Nomura T; Obayashi K; Ando Y
    Amyloid; 2017 Mar; 24(1):24-29. PubMed ID: 28081656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis.
    Yoshinaga T; Yazaki M; Kametani F; Sekijima Y; Iesato Y; Miyahara T; Tsuchiya-Suzuki A; Sano K; Higuchi K; Ikeda SI
    Amyloid; 2017 Mar; 24(1):17-23. PubMed ID: 28081655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early diagnosis and management of patients with familial ATTR amyloidosis receiving livers from asymptomatic variant TTR carriers.
    Munar-Qués M; Viader-Farré C; Zabay-Becerril JM; Mulet-Ferrer JM
    Amyloid; 2011 Sep; 18(3):172-3. PubMed ID: 21774739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution.
    Said SM; Grogg KL; Smyrk TC
    Hum Pathol; 2015 Apr; 46(4):491-8. PubMed ID: 25649008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid heart disease: a brief review of treatment options.
    Dubrey SW
    Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
    Puig-Carrion GD; Reyentovich A; Katz SD
    Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
    Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
    Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two different types of amyloid deposits--apolipoprotein A-IV and transthyretin--in a patient with systemic amyloidosis.
    Bergström J; Murphy CL; Weiss DT; Solomon A; Sletten K; Hellman U; Westermark P
    Lab Invest; 2004 Aug; 84(8):981-8. PubMed ID: 15146166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
    Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
    J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
    Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
    Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
    Lachmann HJ; Booth DR; Booth SE; Bybee A; Gilbertson JA; Gillmore JD; Pepys MB; Hawkins PN
    N Engl J Med; 2002 Jun; 346(23):1786-91. PubMed ID: 12050338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Lahuerta C; Menao S; Gracia-Gutierrez A; Bueno-Juana E; Guillén N; Sorribas V; Gracia AA; Aibar MA
    Int J Cardiol; 2020 Feb; 301():220-225. PubMed ID: 31740141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis.
    Garcia Y; Collins AB; Stone JR
    Hum Pathol; 2018 Feb; 72():71-79. PubMed ID: 29133141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.
    Park GY; Jamerlan A; Shim KH; An SSA
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
    Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M
    Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.